Partnering to Deliver Breakthrough Therapies

Collaboration is central to our mission of bringing best-in-class treatment options to patients. We actively partner with academic institutions, scientific organizations, biotech companies, and pharmaceutical firms to accelerate the development of innovative therapies.

From early-stage research through to development and commercialization, we engage in strategic partnerships that align with our core values and enhance our ability to make a meaningful impact. Our scientific focus is within the central nervous system (CNS) and the immune system, with the goal of treating neurological diseases and psychiatric disorders.

We welcome interest from potential collaborators who share our ambition to advance science and improve patient outcomes. Our approach to partnering spans the entire value chain, including collaborations with academic and research organisations, biotech and pharmaceutical companies, as well as distribution partners.

In addition, we offer a suite of tailored end-to-end CDMO services, including drug formulation, drug delivery, testing and validation, manufacturing, and market consultancy. We are actively seeking partnerships around these capabilities to further support the development and delivery of innovative therapies.

Connect with Our Business Development Team
We’re always open to meaningful partnerships. Reach out to explore how we can work together across research, development, or CDMO services.

Martin Caspersen
Chief Commercial Officer
Email